New hope for migraine patients: revolutionary therapy in sight!

New hope for migraine patients: revolutionary therapy in sight!

Hamburg, Deutschland - Migraine torture could come to an end soon! Doctors and researchers are optimistic, thanks to new medication that will come onto the market in Germany next year. Affected people like Annika Sandre, who suffers from extreme migraine attacks and is affected up to 25 days a month, hope for a noticeable improvement in their quality of life. According to the latest findings, the new type of active ingredient groups are intended to serve as a potential rescue for millions of migraine patients. According to the Norddeutscher Rundfunk, a new approach to the treatment of this underestimated but serious illness is pursued. Migraine not only causes unbearable pain, but also burdens the German economy with over 100 billion euros annually.

new hope for migraine patients

Research focuses on innovative medication such as CGRP antibodies that should take precedence on migraine attacks, as well as the soon available pantons that not only have a preventive effect, but also alleviate acute seizures. These new therapeutic approaches aim to offer greater effectiveness and improved compatibility, especially for patients who are not allowed to use triptans due to health risks. Prof. Dr. Arne May from the University Hospital Eppendorf emphasizes that panties represent a valuable addition to the existing therapy, since they can also be used in people with cardiovascular diseases.

A comprehensive analysis has also shown that the new medication, including RimeGepant and Lasmiditan, promise significant relief from pain and other symptoms. Clinical studies noticed that these preparations were able to convince in a variety of categories - in particular the long -term effect of RimeGepant was highlighted. These findings, summarized in the review, publishes in the German Health Portal, illustrate progress in migraine research. Pain and accompanying symptoms could soon not only be treated quickly, but also sustainably.

For the millions of people, this is a ray of hope on the horizon, which finally makes the long -held promise of more effective migraine therapy come true. These new treatment options could not only significantly improve the quality of life of the patients, but also save society the high economic costs of the disease. A true progress in pain therapy that also gives hope, as well as Norddeutscher Rundfunk reports and detailed comparisons on new therapies.